RIM
Ranger Investment Management’s Anika Therapeutics ANIK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-140,205
| Closed | -$4.15M | – | 104 |
|
|
2022
Q4 | $4.15M | Buy |
140,205
+3,079
| +2% | +$91.1K | 0.31% | 67 |
|
|
2022
Q3 | $3.26M | Sell |
137,126
-2,535
| -2% | -$60.3K | 0.26% | 70 |
|
|
2022
Q2 | $3.12M | Buy |
139,661
+3,280
| +2% | +$73.2K | 0.24% | 73 |
|
|
2022
Q1 | $3.43M | Buy |
136,381
+8,150
| +6% | +$205K | 0.22% | 69 |
|
|
2021
Q4 | $4.6M | Buy |
128,231
+12
| +0% | +$430 | 0.25% | 66 |
|
|
2021
Q3 | $5.46M | Buy |
128,219
+6,695
| +6% | +$285K | 0.29% | 67 |
|
|
2021
Q2 | $5.26M | Sell |
121,524
-474
| -0.4% | -$20.5K | 0.27% | 63 |
|
|
2021
Q1 | $4.98M | Buy |
121,998
+46,003
| +61% | +$1.88M | 0.27% | 65 |
|
|
2020
Q4 | $3.44M | Buy |
75,995
+22,196
| +41% | +$1M | 0.18% | 71 |
|
|
2020
Q3 | $1.9M | Buy |
+53,799
| New | +$1.9M | 0.12% | 75 |
|
|
2015
Q2 | – | Sell |
-412,720
| Closed | -$17M | – | 128 |
|
|
2015
Q1 | $17M | Buy |
412,720
+1,280
| +0.3% | +$52.7K | 0.83% | 47 |
|
|
2014
Q4 | $16.8M | Buy |
411,440
+394,200
| +2,287% | +$16.1M | 0.86% | 46 |
|
|
2014
Q3 | $632K | Buy |
+17,240
| New | +$632K | 0.03% | 102 |
|